|
Quotes & Info
|
| MEDQ > SEC Filings for MEDQ > Form 8-K on 14-Nov-2008 | All Recent SEC Filings |
14-Nov-2008
Change in Directors or Principal Officers, Financial Statements and Exhibits
(b) On November 10, 2008, Kathleen Donovan, the Company's current Senior Vice President and Chief Financial Officer informed the Company's Chief Executive Officer that she has decided to resign from the Company and accept another employment position, such resignation to be effective as of the close of business on November 21, 2008.
(c) Effective as of the close of business on November 21, 2008, James Brennan will become the Company's interim principal financial officer on a temporary basis until the appointment of a new chief financial officer. Mr. Brennan is currently serving as the Company's Principal Accounting Officer, Controller, Treasurer and Vice President, and will retain such positions while he assumes the interim principal financial officer role. The Company has commenced a search for a permanent chief financial officer.
Mr. Brennan, 61, has served as our Principal Accounting Officer, Vice President, Controller and Treasurer since November 2006. From March 2006 until November 2006, Mr. Brennan served as a consultant to the Company providing Sarbanes-Oxley compliance and financial accounting services. From July 2005 until March 2006, Mr. Brennan operated his own consulting firm, specializing in providing Sarbanes-Oxley compliance and financial accounting services. Between May 2000 and July 2005, Mr. Brennan served as the Vice President of Finance for two divisions of IKON Office Solutions.
(d) As disclosed in the Current Report on Form 8-K filed by the Company with the United States Securities and Exchange Commission (the "SEC") on November 5, 2008, R. Scott Bennett, the Company's former Senior Vice President of Sales and Marketing left the Company to pursue other opportunities effective October 30, 2008. The Company entered into a Separation Agreement and General Release with Mr. Bennett on November 14, 2008 (the "Bennett Separation Agreement") which terminates the employment agreement between the Company and Mr. Bennett dated October 26, 2005 (the "Bennett Employment Agreement").
A description of the Bennett Employment Agreement is contained in the Company's Current Report on Form 8-K filed with the SEC on October 31, 2005 (the "October 2005 8-K"), and such description is incorporated by reference in this Current Report on Form 8-K. In addition, a copy of the Bennett Employment Agreement was filed with the SEC as an exhibit to the October 2005 8-K. The Bennett Separation Agreement provides that Mr. Bennett's employment with us, and the Bennett Employment Agreement, terminated effective as of October 30, 2008. Pursuant to the Bennett Separation Agreement, Mr. Bennett is entitled to receive the severance provided for in the Bennett Employment Agreement. Such severance amounts to $306,033 and is payable in equal installments over 12 months. The Bennett Separation Agreement also provides that, notwithstanding its termination, certain sections of the Bennett Employment Agreement will continue in effect, including those relating to confidentiality, non-competition, non-solicitation and indemnification. The Bennett Separation Agreement also provides that Mr. Bennett releases the Company from claims arising or occurring on or prior to the date of the Bennett Separation Agreement.
A copy of the Bennett Separation Agreement is attached as Exhibit 10.1 to this Form 8-K and is incorporated herein by reference.
The following exhibits are filed with this Form 8-K:
Exhibit No. Description
10.1 Separation Agreement and General Release by and between MedQuist Inc.
and R. Scott Bennett dated November 14, 2008
|
|
|